Phase 1/2

Assets whose furthest-along trial is at this stage.

177Lu-BetaBart
RadiopharmaceuticalPhase 1/2
177Lu-DPI-4452
RadiopharmaceuticalPhase 1/2
2-hydroxybenzylamine acetate
Small moleculePhase 1/2
514G3
Monoclonal antibodyPhase 1/2No recent activity
A2B395
Cell therapyPhase 1/2
A2B530
Cell therapyPhase 1/2
A2B543
Cell therapyPhase 1/2
A2B694
Cell therapyPhase 1/2
AAV1.SERCA2a
Gene therapy / editingPhase 1/2
AB8939
Small moleculePhase 1/2
ABBV-1758
Monoclonal antibodyPhase 1/2
ABBV-2001
Multispecific antibodyPhase 1/2
ABBV-6628
Antibody fragmentPhase 1/2
ABD-3001
Small moleculePhase 1/2
ACI-24.060
VaccinePhase 1/2
AFNT-211
Cell therapyPhase 1/2
AGN-193408
Unknown / undisclosedPhase 1/2
AGuIX
OtherPhase 1/2
AK129
Multispecific antibodyPhase 1/2
AK138D1
Antibody–drug conjugatePhase 1/2
ALE.P02
Antibody–drug conjugatePhase 1/2
ALE.P03
Antibody–drug conjugatePhase 1/2
ALG.APV-527
Multispecific antibodyPhase 1/2No recent activity
ALN-6457
RNA / oligonucleotidePhase 1/2
ALN-CFB
RNA / oligonucleotidePhase 1/2
ALN-SOD
RNA / oligonucleotidePhase 1/2
ALXN2350
Gene therapy / editingPhase 1/2
AMO959
Small moleculePhase 1/2
AMT-260
Gene therapy / editingPhase 1/2
ANS02
Small moleculePhase 1/2
AP203
Multispecific antibodyPhase 1/2
ARD103
Cell therapyPhase 1/2
ARO-ALK7
RNA / oligonucleotidePhase 1/2
ARO-C3
RNA / oligonucleotidePhase 1/2
ARO-DIMER-PA
RNA / oligonucleotidePhase 1/2
ARO-INHBE
RNA / oligonucleotidePhase 1/2
ARO-MAPT-SC
RNA / oligonucleotidePhase 1/2
ARV-806
Small moleculePhase 1/2
ASP2957
Gene therapy / editingPhase 1/2
ASP546C
Antibody–drug conjugatePhase 1/2
AVZO-021
Small moleculePhase 1/2
AVZO-023
Small moleculePhase 1/2
AVZO-1418
Antibody–drug conjugatePhase 1/2
AX-158
Small moleculePhase 1/2
AZD0516
Antibody–drug conjugatePhase 1/2
AZD0754
Cell therapyPhase 1/2
AZD3470
Small moleculePhase 1/2
AZD3632
Small moleculePhase 1/2
AZD4045
Cell therapyPhase 1/2
AZD4512
Antibody–drug conjugatePhase 1/2
AZD4956
Small moleculePhase 1/2
AZD5492
Multispecific antibodyPhase 1/2
AZD6621
Multispecific antibodyPhase 1/2
AZD6750
Biologic (subtype unspecified)Phase 1/2
AZD7760
CombinationPhase 1/2
Actinium (225Ac) oxodotreotide
RadiopharmaceuticalPhase 1/2
Adipose-derived MSC clusters (S.Biomedics)
Cell therapyPhase 1/2
Alintegimod
Small moleculePhase 1/2
Alrizomadlin
Small moleculePhase 1/2
BAY 3713372
Small moleculePhase 1/2
BBT-207
Small moleculePhase 1/2
BBT002
Multispecific antibodyPhase 1/2
BCMA CAR-NK (Shenzhen Pregene Biopharma)
Cell therapyPhase 1/2
BCMA-targeted Prime CAR-T cells (Chongqing Precision Biotech)
Cell therapyPhase 1/2
BEAM-301
Gene therapy / editingPhase 1/2
BEAM-302
Gene therapy / editingPhase 1/2
BEBT-701
RNA / oligonucleotidePhase 1/2
BG1805
Cell therapyPhase 1/2
BGC101
Cell therapyPhase 1/2
BH-30643
Small moleculePhase 1/2
BI-1910
Monoclonal antibodyPhase 1/2
BIIB105
RNA / oligonucleotidePhase 1/2
BL-M02D1
Antibody–drug conjugatePhase 1/2
BLEX 404
PolysaccharidePhase 1/2
BLU-924
Small moleculePhase 1/2
BMS-986449
Small moleculePhase 1/2
BMS-986490
Antibody–drug conjugatePhase 1/2
BMS-986517
Unknown / undisclosedPhase 1/2
BMS-986523
Small moleculePhase 1/2
BMS-986525
Unknown / undisclosedPhase 1/2
BMS-986548
Unknown / undisclosedPhase 1/2
BPI-361175
Small moleculePhase 1/2
BPI-572270
Small moleculePhase 1/2
BSB-1001
Cell therapyPhase 1/2
BT02
Monoclonal antibodyPhase 1/2
Bampidirsen
RNA / oligonucleotidePhase 1/2
Beijing Biotech BCMA/CD19 dual-target CAR-T
Cell therapyPhase 1/2
Beijing Biotech BCMA/CD38 dual-target CAR-T
Cell therapyPhase 1/2
Beijing Biotech BCMA/GPRC5D dual-target CAR-T
Cell therapyPhase 1/2
Beijing Biotech anti-CD19 CAR-T
Cell therapyPhase 1/2
Belantamab
Monoclonal antibodyPhase 1/2
BioTTT001
Oncolytic virusPhase 1/2
Briquilimab
Monoclonal antibodyPhase 1/2
CART84
Cell therapyPhase 1/2
CCTx-001
Cell therapyPhase 1/2
CD123 targeted CAR-NK cells
Cell therapyPhase 1/2
CD123/CD33 CART
Cell therapyPhase 1/2
CIS-DPI
Small moleculePhase 1/2
CJRB-101
Microbiome therapeuticPhase 1/2
CKD-703
Antibody–drug conjugatePhase 1/2
CLN-049
Multispecific antibodyPhase 1/2
COM701
Monoclonal antibodyPhase 1/2
CP-383
Small moleculePhase 1/2
CR-001
Multispecific antibodyPhase 1/2
CRG-150
Cell therapyPhase 1/2
CRMA-1001
Gene therapy / editingPhase 1/2
CS32582
Small moleculePhase 1/2
CT071
Cell therapyPhase 1/2
CTS2190
Small moleculePhase 1/2
Cariprazine long-acting injection (Mapi Pharma)
Small moleculePhase 1/2
Ciforadenant
Small moleculePhase 1/2
DB-1310
Antibody–drug conjugatePhase 1/2
DFT383
Gene therapy / editingPhase 1/2
DJI136
Cell therapyPhase 1/2
DNL126
Protein / enzyme therapeuticPhase 1/2
DS-1103a
Monoclonal antibodyPhase 1/2
DS-3939a
Antibody–drug conjugatePhase 1/2
DS-7011a
Monoclonal antibodyPhase 1/2
DZD6008
Small moleculePhase 1/2
Davutamig
Multispecific antibodyPhase 1/2
Debio 1562M
Antibody–drug conjugatePhase 1/2
Dositinib mesylate
Small moleculePhase 1/2
Dual-target Car-nk Cells
Cell therapyPhase 1/2
EB-SELECT Dual-Target CAR-NK Cells
Cell therapyPhase 1/2
EB-SELECT Single-Target CAR-NK Cells
Cell therapyPhase 1/2
EC5026
Small moleculePhase 1/2
ECI830
Small moleculePhase 1/2
ELE-101
Small moleculePhase 1/2
ENV-501
Antibody–drug conjugatePhase 1/2
ETX101
Gene therapy / editingPhase 1/2
EVM14
VaccinePhase 1/2
Eciruciclib
Small moleculePhase 1/2
EcoActive
Microbiome therapeuticPhase 1/2
Efdelikofusp alfa
Protein / enzyme therapeuticPhase 1/2
Elironrasib
Small moleculePhase 1/2
Eltanexor
Unknown / undisclosedPhase 1/2
Elticertinib
Small moleculePhase 1/2
Enozertinib
Small moleculePhase 1/2
Enzomenib
Small moleculePhase 1/2
Ezobresib
Small moleculePhase 1/2
Ezurpimtrostat
Small moleculePhase 1/2
FMC-376
Small moleculePhase 1/2
FWD1802
Small moleculePhase 1/2
Furestem-CD
Cell therapyPhase 1/2No recent activity
GEN-725
Small moleculePhase 1/2
GFH276
Small moleculePhase 1/2
GI-101A
Protein / enzyme therapeuticPhase 1/2
GI-108
Multispecific antibodyPhase 1/2
GIC-102
Cell therapyPhase 1/2
GRWD5769
Small moleculePhase 1/2
GUB-UCN2
PeptidePhase 1/2
GVV858
Unknown / undisclosedPhase 1/2
Gozanertinib
Small moleculePhase 1/2
H002
Small moleculePhase 1/2
H3B-6545
Small moleculePhase 1/2
HB0036
Multispecific antibodyPhase 1/2
HL-300
Small moleculePhase 1/2
HLX208 + HLX10
CombinationPhase 1/2No recent activity
HLX301
Multispecific antibodyPhase 1/2No recent activity
HRS-1738
Unknown / undisclosedPhase 1/2
HRS-2189
Unknown / undisclosedPhase 1/2
HRS-6208
Unknown / undisclosedPhase 1/2
HRS-6768
Unknown / undisclosedPhase 1/2
HRS-8364
Unknown / undisclosedPhase 1/2
HS-001
Cell therapyPhase 1/2
HS235
PeptidePhase 1/2
HYP-6589
Small moleculePhase 1/2
Hepadvax
VaccinePhase 1/2
HuL001
Monoclonal antibodyPhase 1/2
HucMSC intramyocardial therapy
Cell therapyPhase 1/2
Human Serum Albumin/interferon alpha2b fusion protein
Biologic (subtype unspecified)Phase 1/2No recent activity
IAM1363
Small moleculePhase 1/2
IAP0971
Protein / enzyme therapeuticPhase 1/2
ICP-490
Small moleculePhase 1/2
IDE-161
Small moleculePhase 1/2
IDP-001
Antibody–drug conjugatePhase 1/2
IDP-023
Cell therapyPhase 1/2
IDP-121
Small moleculePhase 1/2
IMC-003
Biologic (subtype unspecified)Phase 1/2
INV-6452
Small moleculePhase 1/2
INV-8989
Small moleculePhase 1/2
ION337
RNA / oligonucleotidePhase 1/2
IOV-4001
Cell therapyPhase 1/2
ITU512
Small moleculePhase 1/2
Ifezuntirgene inilparvovec
Gene therapy / editingPhase 1/2
Imneskibart
Monoclonal antibodyPhase 1/2
Invikafusp alfa
Multispecific antibodyPhase 1/2
JAB-23E73
Small moleculePhase 1/2
JIN-A02
Small moleculePhase 1/2
JK08
Protein / enzyme therapeuticPhase 1/2
JL18008
Protein / enzyme therapeuticPhase 1/2
JMT202
Monoclonal antibodyPhase 1/2
KB707
Gene therapy / editingPhase 1/2
KIT2014
PeptidePhase 1/2
KN060
Monoclonal antibodyPhase 1/2
KQ-2003
Cell therapyPhase 1/2
LBL-034
Multispecific antibodyPhase 1/2
LCB84
Antibody–drug conjugatePhase 1/2
LM11A-31
Small moleculePhase 1/2
LP-98
PeptidePhase 1/2
LW231
Unknown / undisclosedPhase 1/2
LX1001
Gene therapy / editingPhase 1/2
LYL273
Cell therapyPhase 1/2
LYT-200
Monoclonal antibodyPhase 1/2
Ligufalimab
Monoclonal antibodyPhase 1/2
Linepemat (IRL757)
Small moleculePhase 1/2
Lithium salicylate/L-proline (AL001)
Small moleculePhase 1/2
Lunbotinib
Small moleculePhase 1/2
M701
Multispecific antibodyPhase 1/2
MB-001
Monoclonal antibodyPhase 1/2
MBS314
Unknown / undisclosedPhase 1/2
MDNA11
Protein / enzyme therapeuticPhase 1/2
MET-233i
PeptidePhase 1/2
MK-3120
Unknown / undisclosedPhase 1/2
MRX-2843
Small moleculePhase 1/2
MS-553
Small moleculePhase 1/2
Mavrostobart
Monoclonal antibodyPhase 1/2
Melevodopa/carbidopa (Sirio)
Small moleculePhase 1/2No recent activity
Menstrual blood-derived mesenchymal stem cells (MenSCs)
Cell therapyPhase 1/2No recent activity
Micvotabart pelidotin
Antibody–drug conjugatePhase 1/2
Mobinitinib
Small moleculePhase 1/2
N17350
Biologic (subtype unspecified)Phase 1/2
NC410
Protein / enzyme therapeuticPhase 1/2
NDI-101150
Small moleculePhase 1/2
NEO212
Small moleculePhase 1/2
NGM707
Monoclonal antibodyPhase 1/2
NSC001
Small moleculePhase 1/2
Nadunolimab
Monoclonal antibodyPhase 1/2
Nebratamig
Multispecific antibodyPhase 1/2
Nezastomig
Multispecific antibodyPhase 1/2
Nezutatug
Monoclonal antibodyPhase 1/2
Nivudirsen (BMN 351)
RNA / oligonucleotidePhase 1/2
Nula-cel
Gene or cell therapy (subtype unspecified)Phase 1/2
OBX-115
Cell therapyPhase 1/2
ODX (Osteodex)
Small moleculePhase 1/2
OPC-415
Cell therapyPhase 1/2
OPK-88006
Unknown / undisclosedPhase 1/2
OR502
Monoclonal antibodyPhase 1/2
OSE-279
Monoclonal antibodyPhase 1/2
Ocifisertib
Small moleculePhase 1/2
Olsutamig
Multispecific antibodyPhase 1/2
OrcaGraft (Orca-Q)
Cell therapyPhase 1/2
OriCAR-017
Cell therapyPhase 1/2
Orvanesib
Small moleculePhase 1/2
PA1010
Unknown / undisclosedPhase 1/2No recent activity
PB-718
PeptidePhase 1/2
PDC*lung01
VaccinePhase 1/2
PH009-1
Small moleculePhase 1/2
PR001 (LY3884961)
Gene therapy / editingPhase 1/2
Palacaparib
Small moleculePhase 1/2
Pamlectabart tismanitin
Antibody–drug conjugatePhase 1/2
Pegenzileukin
Protein / enzyme therapeuticPhase 1/2
Pepinemab
Monoclonal antibodyPhase 1/2
PolyCore
OtherPhase 1/2
QLC1101
Small moleculePhase 1/2
QLS1304
Small moleculePhase 1/2
QLS5132
Antibody–drug conjugatePhase 1/2
Quaratusugene Ozeplasmid · Reqorsa
Gene therapy / editingPhase 1/2
R289
Small moleculePhase 1/2
REGN10597
Multispecific antibodyPhase 1/2
REGN15505
Multispecific antibodyPhase 1/2
REGN17372
Multispecific antibodyPhase 1/2
REGN22530
Monoclonal antibodyPhase 1/2
REGN5668
Multispecific antibodyPhase 1/2
REGN7945
Multispecific antibodyPhase 1/2
REGV131-LNP1265
Gene therapy / editingPhase 1/2
RM-718
PeptidePhase 1/2
RN0361
RNA / oligonucleotidePhase 1/2
RNDP-001
Cell therapyPhase 1/2
RYZ801
RadiopharmaceuticalPhase 1/2
Raguneprocel (Amchepry)
Cell therapyPhase 1/2
Rezorstobart
Monoclonal antibodyPhase 1/2
Ristoglogene autogetemcel
Gene therapy / editingPhase 1/2
Rogocekib
Small moleculePhase 1/2
S230815
RNA / oligonucleotidePhase 1/2
S241656
Small moleculePhase 1/2
SAR402663
Gene therapy / editingPhase 1/2
SAR439459
Biologic (subtype unspecified)Phase 1/2
SAR446268
Gene therapy / editingPhase 1/2
SAR446597
Gene therapy / editingPhase 1/2
SCM-AGH
Cell therapyPhase 1/2No recent activity
SENL103
Cell therapyPhase 1/2
SG2918
Antibody–drug conjugatePhase 1/2
SHR-1681
Unknown / undisclosedPhase 1/2
SHR-2005
Unknown / undisclosedPhase 1/2
SHR-4298
Unknown / undisclosedPhase 1/2
SHR-4375
Antibody–drug conjugatePhase 1/2
SHR-4394
Antibody–drug conjugatePhase 1/2
SHR-4610
Unknown / undisclosedPhase 1/2
SHR-7787
Multispecific antibodyPhase 1/2
SHR-9803
Unknown / undisclosedPhase 1/2
SL-28
Cell therapyPhase 1/2
SMP3124LP
Small moleculePhase 1/2
SRP-1001
RNA / oligonucleotidePhase 1/2
SRP-1003
RNA / oligonucleotidePhase 1/2
SRSD216
RNA / oligonucleotidePhase 1/2
STI-6129
Antibody–drug conjugatePhase 1/2
STK-012
Protein / enzyme therapeuticPhase 1/2
STMC-103H
Microbiome therapeuticPhase 1/2
STX-241
Small moleculePhase 1/2
SYS6090
Protein / enzyme therapeuticPhase 1/2
Sabestomig
Multispecific antibodyPhase 1/2
Selcodebart
Monoclonal antibodyPhase 1/2
Silevertinib
Small moleculePhase 1/2
Solnerstotug
Monoclonal antibodyPhase 1/2
Surzetoclax
Small moleculePhase 1/2
T3011
Oncolytic virusPhase 1/2
TAK-188
Unknown / undisclosedPhase 1/2
TAK-505
Unknown / undisclosedPhase 1/2
TAK-921
Antibody–drug conjugatePhase 1/2
TB511
PeptidePhase 1/2
TED-A9 (A9-DPC)
Cell therapyPhase 1/2
TGRX-814
Small moleculePhase 1/2
TH9619
Small moleculePhase 1/2
TNG456
Small moleculePhase 1/2
TQA3038
Unknown / undisclosedPhase 1/2
TSN1611
Small moleculePhase 1/2
TSRA-196
Gene therapy / editingPhase 1/2
TT-10
Small moleculePhase 1/2
TT-4
Small moleculePhase 1/2
TUB-030
Antibody–drug conjugatePhase 1/2
TX200
Cell therapyPhase 1/2
Tambiciclib
Small moleculePhase 1/2
Tecaginlimab
Monoclonal antibodyPhase 1/2
Tegtociclib
Small moleculePhase 1/2
Temferon
Gene therapy / editingPhase 1/2
Troculeucel
Cell therapyPhase 1/2
Trovocabtagene autoleucel (C-CAR088)
Cell therapyPhase 1/2
Tuspetinib
Small moleculePhase 1/2
Tuvutromstat
Small moleculePhase 1/2
U32 CAR-T
Cell therapyPhase 1/2
UX-DA003
Cell therapyPhase 1/2
VERT-002
Monoclonal antibodyPhase 1/2
VGN-R08b
Gene therapy / editingPhase 1/2
VGN-R09b
Gene therapy / editingPhase 1/2
VMD-102
Small moleculePhase 1/2
VMD-928
Small moleculePhase 1/2
VRN110755
Small moleculePhase 1/2
VT3989
Small moleculePhase 1/2
VY7523
Monoclonal antibodyPhase 1/2
Vedastotug
Monoclonal antibodyPhase 1/2
Vemzatatug vedotin
Antibody–drug conjugatePhase 1/2
Vepafestinib
Small moleculePhase 1/2
Vevoctadekin
Biologic (subtype unspecified)Phase 1/2
Vonsetamig
Unknown / undisclosedPhase 1/2
Vopimetostat
Small moleculePhase 1/2
Vosilasarm
Small moleculePhase 1/2
Vustanaciclib
Small moleculePhase 1/2
WEF-001
OtherPhase 1/2
WTX-330
Biologic (subtype unspecified)Phase 1/2
WVE-003
RNA / oligonucleotidePhase 1/2
WVE-006
RNA / oligonucleotidePhase 1/2
WVE-007
RNA / oligonucleotidePhase 1/2
XS-411
Cell therapyPhase 1/2
XTX501
Multispecific antibodyPhase 1/2
XYA02
Antibody–drug conjugatePhase 1/2
XZP-5955
Small moleculePhase 1/2
XmAb942
Monoclonal antibodyPhase 1/2
YH32364
Multispecific antibodyPhase 1/2
YH42946
Small moleculePhase 1/2
Zedoresertib
Small moleculePhase 1/2
Zevorcabtagene autoleucel
Cell therapyPhase 1/2
Zirdafulven
Small moleculePhase 1/2
Zocaglusagene nuzaparvovec
Gene therapy / editingPhase 1/2
Zugocabtagene geleucel
Cell therapyPhase 1/2
aritinercept
Protein / enzyme therapeuticPhase 1/2
atamparib
Small moleculePhase 1/2
isaralgagene civaparvovec
Gene therapy / editingPhase 1/2
mRNA-2808
RNA / oligonucleotidePhase 1/2
rezatapopt
Small moleculePhase 1/2

← all assets